UBS lowered the firm’s price target on Syndax (SNDX) to $37 from $38 and keeps a Buy rating on the shares.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SNDX:
- Syndax reports 12 Revuforj abstracts accepted for EHA
- Syndax price target raised to $46 from $45 at Stifel
- Syndax price target lowered to $37 from $40 at Jefferies
- Analyst Reiterates Buy on Syndax as Commercial Momentum Builds and Clinical Data Strengthens, Maintains $40 Price Target
- Syndax price target raised to $37 from $35 at Barclays